To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UBE2J2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
531 supporting clones for gene UBE2J2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM172466 brain, hippocampus UBE2J2.a 1 to 583 4 to 586   tiling clone,   586/586
(100 %)
7 diff
(98.9 %id)
CT001381 T-Lymphocytes UBE2J2.a 31 to 356 1 to 326       326/332
(98 %)
1 diff
(99.7 %id)
BI561749 testis UBE2J2.a 331 to 1055 1 to 734       734/736
(99 %)
16 diff
(97.9 %id)
TI_44350347   UBE2J2.a 332 to 1055 123 to 855       733/857
(85 %)
20 diff
(97.7 %id)
DB461549 testis UBE2J2.a 334 to 826 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
DB453932 testis UBE2J2.a 336 to 824 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BI830569 brain, medulla UBE2J2.a 369 to 1292 1 to 924   tiling clone,   924/926
(99 %)
18 diff
(98.1 %id)
TI_57171275   UBE2J2.a 369 to 1292 72 to 995       924/997
(92 %)
23 diff
(97.7 %id)
BM919075 pooled pancreas and spleen UBE2J2.b 1 to 812 19 to 837   tiling clone,   819/1074
(76 %)
39 diff
(96.4 %id)
BM919055 pooled pancreas and spleen UBE2J2.b 3 to 830 1 to 835   tiling clone,   835/1049
(79 %)
33 diff
(96.9 %id)
NM_194315.1   UBE2J2.c 1 to 2314 1 to 2314 exact RefSeq,   2314/2315
(99 %)
5 diff
(99.8 %id)
BM544827 brain, hippocampus UBE2J2.c 22 to 917 25 to 927   tiling clone,   903/1079
(83 %)
20 diff
(98.2 %id)
DA155742 amygdala UBE2J2.c 23 to 571 2 to 551   tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
BX354106 Neuroblastoma Cot 25-normalized UBE2J2.c 47 to 934 1 to 888   tiling clone,   888/888
(100 %)
3 diff
(99.7 %id)
CT000993 T-Lymphocytes UBE2J2.d 1 to 808 1 to 810 A233G P234A A236G V237R N239K ... tiling clone,   810/810
(100 %)
2 diff
(99.8 %id)
DR007168 Spleen UBE2J2.e 1 to 603 13 to 618   tiling clone,   606/618
(98 %)
6 diff
(99.1 %id)
AA442034   UBE2J2.e 31 to 641 1 to 439       433/439
(98 %)
8 diff
(98.2 %id)
CR607169 Placenta Cot 25-normalized UBE2J2.e 35 to 1397 1 to 1363 exact tiling clone,   1363/1363
(100 %)
0 diff
(100 %id)
BX339632 Placenta Cot 25-normalized UBE2J2.e 35 to 547 1 to 512   fully sequenced,   512/512
(100 %)
2 diff
(99.7 %id)
BU521698 leiomyosarcoma, uterus UBE2J2.e 117 to 992 1 to 877       877/878
(99 %)
12 diff
(98.7 %id)
BM807962 ovary (pool of 3) UBE2J2.e 236 to 1033 1 to 816       816/1136
(71 %)
39 diff
(96.6 %id)
BX339631 Placenta Cot 25-normalized UBE2J2.e 486 to 1397 914 to 1   fully sequenced,   914/914
(100 %)
6 diff
(99.4 %id)
AA441924   UBE2J2.e 1332 to 1788 459 to 3   tiling clone,   457/461
(99 %)
0 diff
(100 %id)
BU188203 melanotic melanoma, skin UBE2J2.f 1 to 713 1 to 716   tiling clone,   716/843
(84 %)
16 diff
(98.2 %id)
DA795774 brain UBE2J2.f 18 to 476 2 to 461   capped   460/460
(100 %)
1 diff
(99.8 %id)
CR590185 Neuroblastoma Cot 50-normalized UBE2J2.f 22 to 1298 1 to 1277 exact tiling clone,   1277/1277
(100 %)
0 diff
(100 %id)
DA837477 placenta UBE2J2.f 24 to 569 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA869059 Prostate UBE2J2.f 28 to 547 2 to 522   capped   521/521
(100 %)
4 diff
(99.3 %id)
CR981910 T-Lymphocytes UBE2J2.f 29 to 672 1 to 644       644/651
(98 %)
1 diff
(99.9 %id)
NM_058167.2   UBE2J2.f 32 to 2297 1 to 2266 exact RefSeq,   2266/2267
(99 %)
5 diff
(99.8 %id)
DA883155   UBE2J2.f 32 to 596 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA900464 skeletal muscle UBE2J2.f 32 to 449 2 to 418   capped   417/417
(100 %)
1 diff
(99.8 %id)
DA917295 small intestine UBE2J2.f 32 to 554 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
BC094777 Placenta, pre-eclamptic UBE2J2.f 33 to 2289 1 to 2258 exact tiling clone, AAA   2258/2258
(100 %)
2 diff
(100.0 %id)
TI_57171628   UBE2J2.f 34 to 910 62 to 938       877/945
(92 %)
15 diff
(98.5 %id)
TI_57176492   UBE2J2.f 35 to 638 31 to 644       614/649
(94 %)
21 diff
(96.8 %id)
DA499459 brain UBE2J2.f 36 to 604 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
BG680537 skin, squamous cell carcinoma UBE2J2.f 38 to 959 1 to 918       918/965
(95 %)
16 diff
(98.4 %id)
BX335785 Placenta Cot 25-normalized UBE2J2.f 39 to 1044 1 to 998 P191S F245L A246L Y247T T248R ...     998/1072
(93 %)
20 diff
(98.2 %id)
BG499172 adenocarcinoma, Prostate UBE2J2.f 39 to 716 1 to 682       682/810
(84 %)
15 diff
(98.2 %id)
BX376932 Neuroblastoma Cot 50-normalized UBE2J2.f 40 to 1178 1 to 1126 R8X D27X L233W A234R N235T ...     1126/1135
(99 %)
33 diff
(97.1 %id)
BX399064 Placenta Cot 25-normalized UBE2J2.f 40 to 1035 1 to 983 Y31X P191Q D192X E194R T195R ...     983/983
(100 %)
19 diff
(98.1 %id)
BI836329 pooled pancreas and spleen UBE2J2.f 40 to 907 1 to 865       865/865
(100 %)
22 diff
(97.5 %id)
TI_57162759   UBE2J2.f 40 to 907 29 to 893       865/893
(96 %)
26 diff
(97.1 %id)
CR601173 Placenta Cot 25-normalized UBE2J2.f 41 to 1254 1 to 1214 exact     1214/1214
(100 %)
0 diff
(100 %id)
BX379761 Placenta Cot 25-normalized UBE2J2.f 41 to 665 1 to 624   fully sequenced,   624/624
(100 %)
5 diff
(99.2 %id)
BX361869   UBE2J2.f 41 to 1044 1 to 994 H225Q G231X A243Q A244P F245X ...     994/997
(99 %)
19 diff
(98.1 %id)
BX384103   UBE2J2.f 41 to 1013 1 to 971 K7X R23X K25X C33X A34X ...     971/971
(100 %)
14 diff
(98.6 %id)
BI827980 brain, medulla UBE2J2.f 42 to 910 1 to 868       868/875
(99 %)
10 diff
(98.9 %id)
BI829908 brain, medulla UBE2J2.f 42 to 638 1 to 607       607/612
(99 %)
17 diff
(97.3 %id)
BQ423751 melanotic melanoma, skin UBE2J2.f 42 to 707 12 to 679       668/894
(74 %)
14 diff
(98.5 %id)
TI_57173801   UBE2J2.f 42 to 800 24 to 787       764/788
(96 %)
10 diff
(98.8 %id)
BP207734 coronary artery UBE2J2.f 43 to 603 1 to 561       561/561
(100 %)
7 diff
(98.8 %id)
BX375071 Neuroblastoma Cot 25-normalized UBE2J2.f 43 to 1061 1 to 1012 S5N M80I N150X L151X L233W ...     1012/1018
(99 %)
18 diff
(98.3 %id)
BX334743.
matches multiple genes
Placenta Cot 25-normalized UBE2J2.f 44 to 975 30 to 964     also hits gene NDN 935/964
(96 %)
14 diff
(98.6 %id)
BX339268 Placenta Cot 25-normalized UBE2J2.f 44 to 983 1 to 942       867/942
(92 %)
14 diff
(98.6 %id)
DA500829 brain UBE2J2.f 44 to 595 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA774209 brain UBE2J2.f 44 to 640 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
DB129679 thymus UBE2J2.f 44 to 582 2 to 540   capped   539/540
(99 %)
1 diff
(99.9 %id)
DA025160   UBE2J2.f 46 to 619 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA455008 tongue, tumor tissue UBE2J2.f 46 to 554 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
DA042144 bladder UBE2J2.f 47 to 421 2 to 377   capped   376/382
(98 %)
2 diff
(99.5 %id)
BI825959 brain, medulla UBE2J2.f 48 to 800 1 to 758       758/759
(99 %)
5 diff
(99.4 %id)
TI_57242251   UBE2J2.f 49 to 706 29 to 689       661/689
(95 %)
6 diff
(99.2 %id)
CR610022 B cells (Ramos cell line) Cot 25-normalized UBE2J2.f 50 to 1279 1 to 1230 exact     1230/1230
(100 %)
0 diff
(100 %id)
BX342929   UBE2J2.f 50 to 423 1 to 374   fully sequenced,   374/374
(100 %)
3 diff
(99.2 %id)
BQ072441 pooled lung and spleen UBE2J2.f 50 to 775 68 to 799       732/1146
(63 %)
27 diff
(97.7 %id)
DA580245   UBE2J2.f 51 to 609 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
TI_57170227   UBE2J2.f 51 to 863 25 to 839       815/839
(97 %)
13 diff
(98.5 %id)
BP263862 small intestine UBE2J2.f 52 to 629 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP264668 umbilical vein UBE2J2.f 52 to 622 1 to 572       572/572
(100 %)
4 diff
(99.4 %id)
EB385959 eye, optic nerve UBE2J2.f 52 to 895 1 to 844       844/844
(100 %)
5 diff
(99.5 %id)
DA729257   UBE2J2.f 52 to 778 2 to 729   capped   728/767
(94 %)
5 diff
(99.4 %id)
AK075017 ovary, tumor tissue UBE2J2.f 53 to 1733 1 to 1681 S2N F100S available from FLJ,   1681/1747
(96 %)
8 diff
(99.6 %id)
AK291935   UBE2J2.f 53 to 1336 1 to 1284 exact     1284/1284
(100 %)
0 diff
(100 %id)
DA021976   UBE2J2.f 53 to 631 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BX364602 Neuroblastoma Cot 25-normalized UBE2J2.f 53 to 978 33 to 956       924/956
(96 %)
6 diff
(99.4 %id)
BX376344 Neuroblastoma Cot 25-normalized UBE2J2.f 53 to 1044 33 to 1016 F245L A246L Y247T T248R V249S ...     984/1065
(92 %)
16 diff
(98.5 %id)
BX376609 Neuroblastoma Cot 50-normalized UBE2J2.f 53 to 885 33 to 865   fully sequenced,   833/865
(96 %)
7 diff
(99.2 %id)
DT216750 brain UBE2J2.f 53 to 658 1 to 606       606/606
(100 %)
3 diff
(99.6 %id)
DT216846 brain UBE2J2.f 53 to 715 1 to 662       662/662
(100 %)
0 diff
(100 %id)
BI917190 brain UBE2J2.f 53 to 706 1 to 657       657/657
(100 %)
3 diff
(99.6 %id)
TI_45379770   UBE2J2.f 53 to 881 66 to 900   fully sequenced,   835/900
(92 %)
20 diff
(97.8 %id)
TI_57198212   UBE2J2.f 53 to 819 27 to 793       767/793
(96 %)
18 diff
(97.8 %id)
TI_57174128   UBE2J2.f 53 to 639 31 to 623       593/626
(94 %)
13 diff
(98.0 %id)
TI_57243799   UBE2J2.f 53 to 989 28 to 978       951/978
(97 %)
43 diff
(95.7 %id)
DA749043   UBE2J2.f 53 to 625 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA764451 tongue UBE2J2.f 53 to 519 2 to 471   capped   470/470
(100 %)
2 diff
(99.6 %id)
BM772337 stomach UBE2J2.f 53 to 683 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
DA914580   UBE2J2.f 53 to 614 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB047892 testis UBE2J2.f 53 to 604 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA011907 adrenal gland UBE2J2.f 54 to 594 2 to 543   capped   542/543
(99 %)
4 diff
(99.3 %id)
DA029837   UBE2J2.f 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA078413 cerebellum UBE2J2.f 54 to 640 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA155374 amygdala UBE2J2.f 54 to 613 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA168654 amygdala UBE2J2.f 54 to 573 2 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DA180135 amygdala UBE2J2.f 54 to 620 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA205074 brain UBE2J2.f 54 to 612 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA300040 hippocampus UBE2J2.f 54 to 630 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA375906 thalamus UBE2J2.f 54 to 554 2 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
DA380981 thalamus UBE2J2.f 54 to 605 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA439517 tongue, tumor tissue UBE2J2.f 54 to 630 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA477942   UBE2J2.f 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA527009 brain UBE2J2.f 54 to 613 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA531208 brain UBE2J2.f 54 to 656 2 to 604   capped   603/603
(100 %)
1 diff
(99.9 %id)
DA549744   UBE2J2.f 54 to 591 2 to 541   capped   540/540
(100 %)
3 diff
(99.5 %id)
DA575383   UBE2J2.f 54 to 612 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA586115 lung UBE2J2.f 54 to 650 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
BF035520 adenocarcinoma, ovary UBE2J2.f 54 to 657 1 to 610       610/1055
(57 %)
13 diff
(98.8 %id)
DA615510   UBE2J2.f 54 to 578 2 to 527   capped   526/526
(100 %)
4 diff
(99.3 %id)
DA621072 Kidney UBE2J2.f 54 to 831 2 to 782   capped   781/800
(97 %)
14 diff
(98.3 %id)
DA678975   UBE2J2.f 54 to 594 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
DA691471   UBE2J2.f 54 to 622 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DA694170   UBE2J2.f 54 to 619 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA697016   UBE2J2.f 54 to 619 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA707457   UBE2J2.f 54 to 594 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA747595   UBE2J2.f 54 to 609 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA777966 brain UBE2J2.f 54 to 623 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA811805 ovary, tumor tissue UBE2J2.f 54 to 780 2 to 730   capped   729/729
(100 %)
7 diff
(99.1 %id)
DA818701   UBE2J2.f 54 to 614 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA848110 placenta UBE2J2.f 54 to 625 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA904611   UBE2J2.f 54 to 578 2 to 526   capped   525/530
(99 %)
3 diff
(99.5 %id)
DA958276 Spleen UBE2J2.f 54 to 610 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB001502 breast, tumor tissue UBE2J2.f 54 to 613 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB114660 thymus UBE2J2.f 54 to 611 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB173261 kidney, tumor tissue UBE2J2.f 54 to 627 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DB209383 trachea UBE2J2.f 54 to 594 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB250596 uterus UBE2J2.f 54 to 654 2 to 602   capped   601/601
(100 %)
2 diff
(99.7 %id)
DB251682 uterus UBE2J2.f 54 to 585 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DB262063 uterus UBE2J2.f 54 to 608 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BI826520 brain, medulla UBE2J2.f 55 to 639 1 to 591       591/594
(99 %)
7 diff
(98.9 %id)
BI819980 pooled brain, lung, testis UBE2J2.f 55 to 819 1 to 765       765/765
(100 %)
15 diff
(98.1 %id)
BI488887 brain UBE2J2.f 55 to 881 1 to 833   fully sequenced,   833/833
(100 %)
14 diff
(98.4 %id)
BI917635 brain UBE2J2.f 55 to 989 1 to 949       949/949
(100 %)
38 diff
(96.0 %id)
BX461935 brain, fetal brain UBE2J2.f 56 to 1065 32 to 1041 R8X G231W A232R L233P A234G ...     1010/1041
(97 %)
18 diff
(98.3 %id)
BG724059 testis UBE2J2.f 56 to 602 1 to 547       547/547
(100 %)
4 diff
(99.3 %id)
CV805062 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE2J2.f 56 to 750 1 to 695       695/696
(99 %)
8 diff
(98.9 %id)
DA999243 breast, tumor tissue UBE2J2.f 56 to 587 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BI825180 brain, medulla UBE2J2.f 58 to 863 1 to 808       808/808
(100 %)
8 diff
(99.1 %id)
BM543861 ovary (pool of 3) UBE2J2.f 58 to 926 1 to 871       871/1055
(82 %)
18 diff
(98.3 %id)
BQ214501 melanotic melanoma, skin UBE2J2.f 58 to 800 13 to 758       746/913
(81 %)
19 diff
(98.0 %id)
CV803718 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE2J2.f 59 to 799 1 to 734       734/841
(87 %)
12 diff
(98.6 %id)
TI_57200539   UBE2J2.f 61 to 920 29 to 895       867/896
(96 %)
19 diff
(97.9 %id)
DA593348 lung UBE2J2.f 62 to 606 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB459888 testis UBE2J2.f 64 to 513 1 to 450       450/450
(100 %)
0 diff
(100 %id)
DB461377 testis UBE2J2.f 64 to 547 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BF791771 adrenal cortex carcinoma, cell line, adrenal gland UBE2J2.f 64 to 714 14 to 675       662/1147
(57 %)
19 diff
(98.4 %id)
BI911725 leukocyte UBE2J2.f 64 to 913 1 to 853       853/856
(99 %)
13 diff
(98.5 %id)
TI_57233822   UBE2J2.f 64 to 913 1 to 853       853/856
(99 %)
13 diff
(98.5 %id)
CR592102 neuroblastoma UBE2J2.f 65 to 1281 1 to 1217 exact     1217/1217
(100 %)
0 diff
(100 %id)
BX404668 neuroblastoma UBE2J2.f 65 to 1019 1 to 954 V47X L159X P191S Q203X L236X ...     954/954
(100 %)
8 diff
(99.2 %id)
BX404669 neuroblastoma UBE2J2.f 65 to 1007 1 to 940 A34X N84X D103X N106X T113X ...     940/944
(99 %)
17 diff
(98.2 %id)
BX438534 neuroblastoma UBE2J2.f 65 to 1044 1 to 977 S2X R8M D27X A34T V47F ...     977/1043
(93 %)
40 diff
(96.2 %id)
BI821390 pooled brain, lung, testis UBE2J2.f 65 to 920 1 to 863       863/864
(99 %)
14 diff
(98.4 %id)
CR982329 T-Lymphocytes UBE2J2.f 67 to 725 1 to 659       659/670
(98 %)
1 diff
(99.9 %id)
DR006554 Spleen UBE2J2.f 67 to 634 40 to 607       568/607
(93 %)
9 diff
(98.6 %id)
BG035527 adenocarcinoma, cell line, Liver UBE2J2.f 68 to 893 1 to 818       818/907
(90 %)
34 diff
(96.3 %id)
BX352721 Neuroblastoma Cot 10-normalized UBE2J2.f 69 to 932 1 to 862       862/862
(100 %)
5 diff
(99.5 %id)
BG167306 hypernephroma, cell line, Kidney UBE2J2.f 69 to 811 1 to 738       738/950
(77 %)
22 diff
(97.7 %id)
BQ226318 embryonal carcinoma, cell line, testis UBE2J2.f 69 to 572 1 to 509       509/1164
(43 %)
11 diff
(99.1 %id)
CN347166 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells UBE2J2.f 70 to 698 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BX397638 Placenta Cot 25-normalized UBE2J2.f 70 to 1116 1 to 1046 exact     1046/1046
(100 %)
5 diff
(99.6 %id)
BQ220844 large cell carcinoma, lung UBE2J2.f 70 to 716 1 to 648       648/933
(69 %)
24 diff
(97.5 %id)
BX355351 Neuroblastoma Cot 50-normalized UBE2J2.f 71 to 1044 1 to 965 D27X Y31*     965/1069
(90 %)
17 diff
(98.5 %id)
BX397336.
matches multiple genes
Placenta Cot 25-normalized UBE2J2.f 71 to 1084 1 to 1013 S5X D27N L42A E43R W44V ...   also hits gene C20orf43 1013/1045
(96 %)
20 diff
(98.1 %id)
CN347162 embryonic stem cells, DMSO-treated H9 cellline UBE2J2.f 73 to 768 1 to 697       697/697
(100 %)
2 diff
(99.8 %id)
BX361201 Placenta Cot 25-normalized UBE2J2.f 73 to 1142 1 to 1050 T11A P210R V213S P214Q N215T ...     1050/1050
(100 %)
24 diff
(97.8 %id)
BE747455 adenocarcinoma cell line, ovary UBE2J2.f 73 to 667 43 to 630       586/874
(67 %)
29 diff
(96.7 %id)
BG391351 embryonal carcinoma, cell line, testis UBE2J2.f 73 to 814 1 to 743       743/744
(99 %)
2 diff
(99.8 %id)
AF296658   UBE2J2.f 74 to 1301 1 to 1219 P214Q N215T L216S A217Q L219S ... AAA   1213/1219
(99 %)
13 diff
(99.0 %id)
BX342887   UBE2J2.f 76 to 1050 1 to 969 K152X P187X V189X V190G P191S ...     969/977
(99 %)
18 diff
(98.2 %id)
BF971824 leiomyosarcoma cell line, uterus UBE2J2.f 76 to 881 1 to 799       799/1083
(73 %)
27 diff
(97.6 %id)
BM805619 brain, hippocampus UBE2J2.f 79 to 604 1 to 538       538/1251
(43 %)
29 diff
(97.7 %id)
BM546064 ovary (pool of 3) UBE2J2.f 81 to 1045 20 to 998 N215K L216P A217R G218R L219A ...     979/1138
(86 %)
39 diff
(96.6 %id)
CD671697 eye, Iris UBE2J2.f 82 to 709 1 to 628       628/628
(100 %)
0 diff
(100 %id)
AA411279 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.f 82 to 508 1 to 427       427/427
(100 %)
10 diff
(97.7 %id)
BE382927 brain, neuroblastoma UBE2J2.f 90 to 565 1 to 477       477/480
(99 %)
2 diff
(99.6 %id)
BM473968 leiomyosarcoma, uterus UBE2J2.f 93 to 977 1 to 894       894/1027
(87 %)
15 diff
(98.6 %id)
BI859963 breast, mammary adenocarcinoma, cell line UBE2J2.f 96 to 575 1 to 480       480/481
(99 %)
2 diff
(99.6 %id)
TI_57188695   UBE2J2.f 96 to 575 55 to 534       480/481
(99 %)
2 diff
(99.6 %id)
BX382443 Placenta Cot 25-normalized UBE2J2.f 100 to 1169 1 to 1054 E52K L233W A234R N235T L236C ...     1054/1054
(100 %)
20 diff
(98.2 %id)
BM920381 pooled lung and spleen UBE2J2.f 100 to 1149 1 to 1048 F237X T248R V249S K250S Y251T ...     1048/1052
(99 %)
21 diff
(98.1 %id)
BF037192 adenocarcinoma, ovary UBE2J2.f 105 to 829 1 to 724       724/724
(100 %)
11 diff
(98.5 %id)
BG106735 lymph, lymphoma, cell line UBE2J2.f 109 to 964 1 to 844       844/876
(96 %)
37 diff
(95.8 %id)
AA314553 colon UBE2J2.f 125 to 634 1 to 511       511/511
(100 %)
5 diff
(99.1 %id)
BG742860 skin UBE2J2.f 125 to 747 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
BG676009 skin, squamous cell carcinoma UBE2J2.f 142 to 1099 1 to 965 K152N D153R K154*     965/965
(100 %)
15 diff
(98.5 %id)
BE905217 epithelioid carcinoma, Pancreas UBE2J2.f 153 to 874 1 to 724       724/727
(99 %)
9 diff
(98.8 %id)
CN347163 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 UBE2J2.f 165 to 647 1 to 484       484/484
(100 %)
2 diff
(99.6 %id)
BX334850 Placenta Cot 25-normalized UBE2J2.f 177 to 1198 1 to 1018 exact     1018/1018
(100 %)
8 diff
(99.3 %id)
BG421662 Kidney, renal cell adenocarcinoma UBE2J2.f 186 to 932 1 to 748       748/951
(78 %)
6 diff
(99.4 %id)
BF568534 epithelioid carcinoma cell line, Pancreas UBE2J2.f 197 to 825 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
BC104890 Brain, cerebral cortex and lung, PCR rescuedclones UBE2J2.f 208 to 1330 1 to 1123 exact     1123/1123
(100 %)
0 diff
(100 %id)
BC113430 Brain, cerebral cortex and lung, PCR rescuedclones UBE2J2.f 208 to 1340 1 to 1133 exact     1133/1133
(100 %)
1 diff
(100.0 %id)
BC143657 Brain, cerebral cortex and lung, PCR rescuedclones UBE2J2.f 208 to 1340 1 to 1133 exact     1133/1133
(100 %)
1 diff
(100.0 %id)
TI_1241110599   UBE2J2.f 208 to 1310 47 to 1143 Q258H     1097/1201
(91 %)
21 diff
(98.3 %id)
TI_1241111919   UBE2J2.f 208 to 1086 882 to 4 exact     879/1288
(68 %)
0 diff
(100 %id)
TI_1241111925   UBE2J2.f 208 to 641 447 to 14       434/1261
(34 %)
0 diff
(100 %id)
TI_1241112153   UBE2J2.f 208 to 1088 887 to 7 exact     881/1270
(69 %)
3 diff
(99.8 %id)
TI_2194628799   UBE2J2.f 208 to 1328 45 to 1158 exact     1114/1292
(86 %)
8 diff
(99.4 %id)
TI_2194629549   UBE2J2.f 208 to 1327 46 to 1154 Q258H     1109/1216
(91 %)
25 diff
(98.0 %id)
TI_1241111475   UBE2J2.f 219 to 1088 873 to 3 T11I     871/1232
(70 %)
1 diff
(100.0 %id)
AW998469 breast_normal UBE2J2.f 245 to 368 8 to 131       124/135
(91 %)
7 diff
(94.9 %id)
BM753838 stomach UBE2J2.f 247 to 594 1 to 349       349/349
(100 %)
3 diff
(99.2 %id)
BM770137 Ascites, stomach UBE2J2.f 248 to 978 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
BM748151 stomach UBE2J2.f 248 to 871 1 to 624       624/624
(100 %)
2 diff
(99.7 %id)
BM745282 stomach UBE2J2.f 248 to 686 1 to 439       439/439
(100 %)
0 diff
(100 %id)
BM765278 stomach UBE2J2.f 248 to 977 1 to 729       729/729
(100 %)
1 diff
(99.9 %id)
BM765311 stomach UBE2J2.f 248 to 980 1 to 734       734/734
(100 %)
1 diff
(99.9 %id)
BM765709 stomach UBE2J2.f 248 to 703 1 to 456       456/456
(100 %)
0 diff
(100 %id)
BM765800 stomach UBE2J2.f 248 to 854 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BM766232 stomach UBE2J2.f 248 to 858 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BM766171 stomach UBE2J2.f 248 to 865 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BM766032 stomach UBE2J2.f 248 to 866 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM772452 stomach UBE2J2.f 248 to 898 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
BM771758 stomach UBE2J2.f 248 to 927 1 to 679       679/679
(100 %)
3 diff
(99.6 %id)
BM772182 stomach UBE2J2.f 248 to 863 1 to 616       616/618
(99 %)
1 diff
(99.9 %id)
BF339624 brain, glioblastoma with EGFR amplification UBE2J2.f 263 to 981 1 to 713       713/714
(99 %)
9 diff
(98.8 %id)
TI_1243022597   UBE2J2.f 265 to 905 641 to 2       640/641
(99 %)
1 diff
(99.9 %id)
TI_2194629551   UBE2J2.f 290 to 1340 1121 to 67       1055/1175
(89 %)
12 diff
(99.0 %id)
ES313508 beard hair, skin UBE2J2.f 295 to 790 1 to 496       496/496
(100 %)
3 diff
(99.4 %id)
BX404667 neuroblastoma UBE2J2.f 310 to 1281 971 to 1       971/971
(100 %)
12 diff
(98.8 %id)
TI_57190407   UBE2J2.f 322 to 1100 48 to 823       776/776
(100 %)
5 diff
(99.4 %id)
BI856734 breast, mammary adenocarcinoma, cell line UBE2J2.f 323 to 1100 1 to 775       775/775
(100 %)
5 diff
(99.4 %id)
CN365491 embryonic stem cells, DMSO-treated H9 cellline UBE2J2.f 326 to 491 7 to 173       167/173
(96 %)
7 diff
(96.0 %id)
CX762674 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE2J2.f 338 to 1056 1 to 718     Submitted on the opposite strand 718/718
(100 %)
2 diff
(99.8 %id)
BX342928   UBE2J2.f 362 to 1279 915 to 1   fully sequenced,   915/915
(100 %)
5 diff
(99.5 %id)
BX379760 Placenta Cot 25-normalized UBE2J2.f 604 to 1254 652 to 1   fully sequenced,   652/652
(100 %)
11 diff
(98.4 %id)
BI489259 brain UBE2J2.f 851 to 1658 808 to 1   fully sequenced,   808/808
(100 %)
12 diff
(98.6 %id)
TI_45379771   UBE2J2.f 851 to 1667 861 to 46   fully sequenced,   816/861
(94 %)
0 diff
(100 %id)
BX329773 Neuroblastoma Cot 50-normalized UBE2J2.f 855 to 1298 445 to 1   fully sequenced,   445/445
(100 %)
22 diff
(95.1 %id)
AA406297 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.f 894 to 1301 409 to 1       409/409
(100 %)
6 diff
(98.6 %id)
DB371044 ovary, tumor tissue UBE2J2.f 1288 to 1733 504 to 67       438/504
(86 %)
0 diff
(100 %id)
DB320303 Kidney UBE2J2.f 1787 to 2295 509 to 1   tiling clone,   509/509
(100 %)
5 diff
(99.1 %id)
CF127154 Chondrosarcoma Lung Metastasis cell lines, lung UBE2J2.g 1 to 591 1 to 591   tiling clone,   591/591
(100 %)
2 diff
(99.7 %id)
TI_154190281   UBE2J2.g 1 to 781 51 to 813 C142W E143* tiling clone,   763/879
(86 %)
24 diff
(97.3 %id)
DA430936 colon UBE2J2.h -8 to 398 2 to 410   tiling clone, capped   409/409
(100 %)
2 diff
(99.6 %id)
BX380384 Placenta Cot 25-normalized UBE2J2.h 20 to 855 1 to 797   tiling clone,   752/797
(94 %)
34 diff
(95.8 %id)
AK056065   UBE2J2.h 273 to 2440 1 to 2167   tiling clone, available from FLJ,   2167/2167
(100 %)
3 diff
(99.9 %id)
DA687271   UBE2J2.h 274 to 810 2 to 538   capped   537/538
(99 %)
2 diff
(99.7 %id)
DB322988   UBE2J2.h 1875 to 2440 568 to 1   tiling clone,   568/568
(100 %)
4 diff
(99.3 %id)
CN347167 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells UBE2J2.i 1 to 654 1 to 654   tiling clone,   654/654
(100 %)
0 diff
(100 %id)
BM556103 amelanotic melanoma, cell line, skin UBE2J2.i 648 to 1594 18 to 985   tiling clone,   968/1120
(86 %)
38 diff
(96.7 %id)
BM559891 amelanotic melanoma, cell line, skin UBE2J2.i 648 to 1509 18 to 883       866/1084
(79 %)
16 diff
(98.6 %id)
BM562531 amelanotic melanoma, cell line, skin UBE2J2.i 648 to 1376 18 to 754       737/928
(79 %)
20 diff
(97.9 %id)
BM681678 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE2J2.i 819 to 1252 1 to 431   tiling clone, AAA Submitted on the opposite strand 431/471
(91 %)
3 diff
(99.4 %id)
BM727299 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE2J2.i 820 to 1252 461 to 32   AAA Submitted on the opposite strand 430/467
(92 %)
0 diff
(100 %id)
R36277 whole brain UBE2J2.i 991 to 1485 1 to 503       503/503
(100 %)
14 diff
(97.3 %id)
R55103 whole brain UBE2J2.i 1017 to 1417 1 to 407       407/476
(85 %)
11 diff
(97.7 %id)
BI063286 uterus_tumor UBE2J2.i 1162 to 1663 1 to 502       502/502
(100 %)
0 diff
(100 %id)
CB046130 2 pooled tumors (clear cell type), Kidney UBE2J2.i 1207 to 1894 10 to 697   tiling clone,   688/697
(98 %)
6 diff
(99.2 %id)
N94887 multiple sclerosis lesions UBE2J2.i 1229 to 1708 1 to 484       484/486
(99 %)
7 diff
(98.6 %id)
BQ636384 eye, retina UBE2J2.i 1347 to 1502 1 to 156       156/156
(100 %)
2 diff
(98.8 %id)
CN347165 embryonic stem cells, cell lines H1, H7, andH9 UBE2J2.i 1784 to 2449 37 to 701   tiling clone,   665/701
(94 %)
6 diff
(99.2 %id)
CB046129 2 pooled tumors (clear cell type), Kidney UBE2J2.i 2147 to 2654 537 to 29   tiling clone, AAA   509/509
(100 %)
2 diff
(99.7 %id)
R49564 whole brain UBE2J2.i 2268 to 2654 433 to 41   tiling clone, AAA   393/416
(94 %)
19 diff
(95.5 %id)
BP420708 small intestine UBE2J2.j 1 to 534 1 to 536   tiling clone, Submitted on the opposite strand 536/536
(100 %)
6 diff
(98.9 %id)
BF973662 leiomyosarcoma cell line, uterus UBE2J2.j 59 to 359 1 to 302       770/958
(80 %)
35 diff
(96.4 %id)
AW408501 lymph UBE2J2.j 63 to 548 8 to 493       486/493
(98 %)
0 diff
(100 %id)
TI_154148096   UBE2J2.j 63 to 735 86 to 754   tiling clone,   669/669
(100 %)
21 diff
(96.9 %id)
AW404831 lymph UBE2J2.j 83 to 626 1 to 544       544/544
(100 %)
5 diff
(99.1 %id)
TI_154141856   UBE2J2.j 90 to 705 82 to 702   tiling clone, AAA   621/694
(89 %)
6 diff
(99.2 %id)
TI_151798185   UBE2J2.j 96 to 693 80 to 684   tiling clone,   605/697
(86 %)
19 diff
(97.3 %id)
DA731028   UBE2J2.k 1 to 813 2 to 813   tiling clone, capped   812/812
(100 %)
10 diff
(98.8 %id)
DB363069   UBE2J2.k 1954 to 2487 529 to 1   tiling clone,   529/530
(99 %)
9 diff
(98.4 %id)
CR605285 HeLa cells Cot 25-normalized UBE2J2.l 1 to 1378 1 to 1378 exact tiling clone,   1378/1378
(100 %)
0 diff
(100 %id)
AL555293 placenta UBE2J2.l 33 to 766 26 to 758   fully sequenced,   733/758
(96 %)
6 diff
(99.3 %id)
BG753301 eye, normal pigmented retinal epithelium UBE2J2.l 294 to 979 1 to 688       688/689
(99 %)
6 diff
(99.2 %id)
BI829740 brain, medulla UBE2J2.l 417 to 1044 1 to 636       636/903
(70 %)
16 diff
(98.3 %id)
TI_57176305   UBE2J2.l 417 to 1044 29 to 664       636/931
(68 %)
22 diff
(97.7 %id)
AL577832 placenta UBE2J2.l 705 to 1378 672 to 1   fully sequenced,   672/672
(100 %)
11 diff
(98.4 %id)
DA175952 amygdala UBE2J2.m 1 to 559 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA538056 Kidney UBE2J2.m 1 to 601 2 to 602   tiling clone, capped   601/601
(100 %)
0 diff
(100 %id)
NM_194457.1   UBE2J2.m 1 to 2135 1 to 2135 exact RefSeq,   2135/2136
(99 %)
5 diff
(99.8 %id)
CB118438 Liver UBE2J2.m 22 to 549 1 to 528       528/528
(100 %)
10 diff
(98.2 %id)
DA540212 lung UBE2J2.m 23 to 600 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BM458668 lymph, lymphoma, cell line UBE2J2.m 37 to 884 1 to 853 H173D H174P V186G I187K F193L ... tiling clone,   853/1082
(78 %)
19 diff
(98.3 %id)
NM_194458.1   UBE2J2.n 1 to 2395 1 to 2395 exact RefSeq,   2395/2396
(99 %)
5 diff
(99.8 %id)
BG112933 Bone, osteosarcoma, cell line UBE2J2.n 6 to 794 1 to 777   tiling clone,   777/1095
(70 %)
21 diff
(98.1 %id)
BM926567 pooled lung and spleen UBE2J2.n 9 to 990 6 to 1005       998/1138
(87 %)
32 diff
(97.2 %id)
DA257666 caudate nucleus UBE2J2.n 12 to 473 2 to 463   capped   462/462
(100 %)
1 diff
(99.8 %id)
DA170375 amygdala UBE2J2.n 13 to 283 2 to 274   capped   273/273
(100 %)
2 diff
(99.3 %id)
DA524109 brain UBE2J2.n 13 to 471 2 to 460   capped   459/459
(100 %)
1 diff
(99.8 %id)
DA306101 hippocampus UBE2J2.n 23 to 614 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
DA615532   UBE2J2.n 23 to 274 2 to 253   capped   252/252
(100 %)
2 diff
(99.3 %id)
DA924838 small intestine UBE2J2.n 23 to 595 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BQ233147 epithelioid carcinoma, Pancreas UBE2J2.n 24 to 811 1 to 798       798/918
(86 %)
22 diff
(97.7 %id)
DA595487 lung UBE2J2.n 26 to 305 2 to 281   capped   280/280
(100 %)
0 diff
(100 %id)
BI091754 cervix UBE2J2.n 27 to 732 1 to 717       717/899
(79 %)
14 diff
(98.5 %id)
BX384958   UBE2J2.n 42 to 1031 1 to 988       988/988
(100 %)
6 diff
(99.4 %id)
BG753315 eye, normal pigmented retinal epithelium UBE2J2.n 71 to 754 1 to 684       684/684
(100 %)
2 diff
(99.8 %id)
BM464116 melanotic melanoma, skin UBE2J2.n 339 to 1298 8 to 965 T196R V197S K198S Y199T V200G ...     958/1077
(88 %)
33 diff
(97.0 %id)
BG685165 B-cells, primary B-cells from tonsils (cell line) UBE2J2.n 456 to 1275 1 to 818 Q117E F190*     818/818
(100 %)
17 diff
(98.0 %id)
BG755717 B-cells, primary B-cells from tonsils (cell line) UBE2J2.n 456 to 1258 1 to 800 F185L V186*     800/800
(100 %)
17 diff
(97.9 %id)
BQ881730 dorsal root ganglia UBE2J2.n 460 to 1325 20 to 885 exact     866/908
(95 %)
17 diff
(98.2 %id)
BG397868 B-cells, primary B-cells from tonsils (cell line) UBE2J2.n 480 to 1360 2 to 878       877/879
(99 %)
17 diff
(98.1 %id)
BX404666 neuroblastoma UBE2J2.n 491 to 1371 882 to 1       882/887
(99 %)
17 diff
(98.1 %id)
EC471890 Prostate UBE2J2.n 491 to 594 105 to 4       102/111
(91 %)
0 diff
(100 %id)
W90647 liver and spleen UBE2J2.n 505 to 951 1 to 450       450/459
(98 %)
10 diff
(97.9 %id)
AA426192 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 539 to 1037 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
AW439303 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE2J2.n 557 to 739 305 to 123       183/305
(60 %)
0 diff
(100 %id)
BG696661 skin UBE2J2.n 559 to 1275 1 to 716       716/716
(100 %)
5 diff
(99.4 %id)
BE775069 uterus UBE2J2.n 575 to 873 3 to 300       298/300
(99 %)
7 diff
(97.7 %id)
BE775090 uterus UBE2J2.n 575 to 873 3 to 300       298/300
(99 %)
7 diff
(97.7 %id)
DA731713   UBE2J2.n 581 to 1329 2 to 756   capped   755/844
(89 %)
24 diff
(97.2 %id)
BG475703 melanotic melanoma, skin UBE2J2.n 582 to 1336 1 to 759   tiling clone,   759/759
(100 %)
6 diff
(99.3 %id)
TI_153959404   UBE2J2.n 590 to 1272 80 to 762       683/957
(71 %)
49 diff
(94.9 %id)
TI_1243022601   UBE2J2.n 594 to 1185 600 to 8       593/600
(98 %)
2 diff
(99.7 %id)
BE728235 melanotic melanoma, skin UBE2J2.n 602 to 1296 1 to 690       690/915
(75 %)
21 diff
(97.8 %id)
TI_227715287   UBE2J2.n 602 to 1399 882 to 96   AAA   787/942
(83 %)
17 diff
(98.2 %id)
AA337765 endometrium UBE2J2.n 605 to 875 1 to 271       271/276
(98 %)
2 diff
(99.3 %id)
CN347164 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 UBE2J2.n 611 to 1045 9 to 443       435/443
(98 %)
8 diff
(98.2 %id)
AW404406 lymph UBE2J2.n 611 to 969 8 to 366       359/366
(98 %)
6 diff
(98.4 %id)
TI_154141292   UBE2J2.n 611 to 1107 80 to 576       497/499
(99 %)
4 diff
(99.2 %id)
AA086122.
matches multiple genes
colon, tumor UBE2J2.n 612 to 1072 1 to 470     also hits gene HMBOX1 470/470
(100 %)
12 diff
(97.5 %id)
BQ690309 ductal carcinoma, cell line, Pancreas UBE2J2.n 615 to 1399 832 to 38   AAA Submitted on the opposite strand 795/934
(85 %)
9 diff
(99.1 %id)
BE262422 brain, neuroblastoma UBE2J2.n 618 to 1203 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BQ673697 epidermoid carcinoma, cell line, salivary gland UBE2J2.n 625 to 1237 1 to 613       613/1001
(61 %)
8 diff
(99.3 %id)
AA354073   UBE2J2.n 631 to 989 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
BG825733 muscle, rhabdomyosarcoma UBE2J2.n 633 to 1322 1 to 696       696/740
(94 %)
17 diff
(97.8 %id)
BE962920 adenocarcinoma, ovary UBE2J2.n 635 to 1399 772 to 17   AAA   756/825
(91 %)
33 diff
(96.0 %id)
BF477703 Prostate UBE2J2.n 643 to 821 181 to 3       179/181
(98 %)
0 diff
(100 %id)
BF338801 brain, glioblastoma with EGFR amplification UBE2J2.n 659 to 1398 1 to 757       757/953
(79 %)
44 diff
(95.4 %id)
BF338876 brain, glioblastoma with EGFR amplification UBE2J2.n 660 to 1391 1 to 724       724/895
(80 %)
16 diff
(98.3 %id)
BP431490   UBE2J2.n 682 to 1088 1 to 407       407/407
(100 %)
1 diff
(99.8 %id)
CB160932 Liver UBE2J2.n 683 to 1204 1 to 522       522/522
(100 %)
0 diff
(100 %id)
BU629745 cell lines, Chondrosarcoma UBE2J2.n 688 to 1399 730 to 19   AAA   712/713
(99 %)
3 diff
(99.6 %id)
AA257965 germinal center B cell UBE2J2.n 698 to 867 1 to 170       170/170
(100 %)
1 diff
(99.5 %id)
BQ015138 Chondrosarcoma, Left Pubic Bone UBE2J2.n 706 to 1399 713 to 19   AAA   695/695
(100 %)
1 diff
(99.9 %id)
CB529058 Aveolar Macrophage, lung UBE2J2.n 706 to 1399 711 to 19   AAA   693/693
(100 %)
1 diff
(99.9 %id)
BP429793   UBE2J2.n 710 to 1067 1 to 358       358/358
(100 %)
4 diff
(98.9 %id)
CA502960 Human Lung Epithelial cells, lung UBE2J2.n 730 to 1399 689 to 19   AAA   671/671
(100 %)
1 diff
(99.9 %id)
BM826026 Ascites, stomach UBE2J2.n 731 to 1285 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
BF223865 carcinoid, lung UBE2J2.n 732 to 1399 685 to 20   AAA   669/677
(98 %)
26 diff
(96.2 %id)
CD365765 Alveolar Macrophage, lung UBE2J2.n 737 to 1399 679 to 19   AAA   661/661
(100 %)
2 diff
(99.7 %id)
BM996672 lung, Metastatic Chondrosarcoma UBE2J2.n 745 to 1399 671 to 19   AAA   653/653
(100 %)
2 diff
(99.7 %id)
AA447862.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 763 to 1296 1 to 534     also hits gene PTPN14 534/534
(100 %)
3 diff
(99.5 %id)
AK098803 thyroid UBE2J2.n 764 to 2387 1 to 1624   tiling clone, available from FLJ,   1624/1624
(100 %)
1 diff
(100.0 %id)
BP268065 thyroid UBE2J2.n 764 to 1343 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
CB145309 Liver UBE2J2.n 774 to 1202 1 to 430       430/430
(100 %)
2 diff
(99.6 %id)
BX093203   UBE2J2.n 779 to 1388 1 to 610   AAA   610/621
(98 %)
2 diff
(99.7 %id)
H72036 breast UBE2J2.n 791 to 1106 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
BM013018 brain, neuroblastoma, cell line UBE2J2.n 791 to 1400 1 to 605       605/619
(97 %)
8 diff
(98.8 %id)
TI_59382256   UBE2J2.n 792 to 1400 103 to 706       604/659
(91 %)
7 diff
(99.0 %id)
AA393664.
matches multiple genes
  UBE2J2.n 801 to 1122 1 to 322     also hits gene jorshaby 322/322
(100 %)
3 diff
(99.1 %id)
CD721856 eye, lacrimal gland UBE2J2.n 805 to 1400 1 to 596       596/599
(99 %)
1 diff
(99.9 %id)
CF264857 Brain glioblastoma UBE2J2.n 810 to 1645 1 to 839       839/839
(100 %)
8 diff
(99.1 %id)
CV575266 cornea, eye UBE2J2.n 814 to 1400 595 to 9     Submitted on the opposite strand 587/595
(98 %)
0 diff
(100 %id)
AI681334 carcinoid, lung UBE2J2.n 819 to 1400 569 to 2       568/578
(98 %)
0 diff
(100 %id)
BE613362 adenocarcinoma, ovary UBE2J2.n 824 to 1325 554 to 27       528/794
(66 %)
0 diff
(100 %id)
BU737307 eye, fetal eyes UBE2J2.n 824 to 1399 594 to 19   AAA   576/576
(100 %)
0 diff
(100 %id)
BI825208 brain, medulla UBE2J2.n 825 to 1378 1 to 555       555/798
(69 %)
4 diff
(99.5 %id)
TI_57170256   UBE2J2.n 825 to 1378 36 to 590       555/833
(66 %)
4 diff
(99.6 %id)
AW139128   UBE2J2.n 827 to 1399 591 to 18   AAA   574/574
(100 %)
3 diff
(99.5 %id)
AA932579 carcinoid, lung UBE2J2.n 832 to 1398 564 to 1       564/564
(100 %)
18 diff
(96.9 %id)
CR612438 Placenta Cot 25-normalized UBE2J2.n 844 to 1400 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BX336830 Placenta Cot 25-normalized UBE2J2.n 844 to 1400 1 to 557       557/557
(100 %)
6 diff
(99.0 %id)
BX386052 Placenta Cot 25-normalized UBE2J2.n 844 to 1400 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BF195273 carcinoid, lung UBE2J2.n 844 to 1400 561 to 5       557/561
(99 %)
0 diff
(100 %id)
CB051899 leiomyosarcoma, soft tissue UBE2J2.n 849 to 1399 600 to 51   AAA   550/551
(99 %)
0 diff
(100 %id)
AI302241 carcinoid, lung UBE2J2.n 864 to 1399 551 to 16   AAA   536/536
(100 %)
1 diff
(99.9 %id)
AI936800 anaplastic oligodendroglioma, brain UBE2J2.n 865 to 1400 542 to 7       536/542
(98 %)
0 diff
(100 %id)
BF792336 adrenal cortex carcinoma, cell line, adrenal gland UBE2J2.n 873 to 1599 1 to 720       720/917
(78 %)
19 diff
(98.0 %id)
AW960628   UBE2J2.n 874 to 1399 1 to 526   AAA   526/526
(100 %)
1 diff
(99.9 %id)
BF588487 colon, colon tumor, RER+ UBE2J2.n 877 to 1093 217 to 1       217/226
(96 %)
14 diff
(93.9 %id)
AA336107 epididymis UBE2J2.n 878 to 1128 1 to 251       251/251
(100 %)
0 diff
(100 %id)
AI492148 B-cell, chronic lymphotic leukemia UBE2J2.n 878 to 1398 521 to 1       521/521
(100 %)
0 diff
(100 %id)
TI_154139411   UBE2J2.n 878 to 1531 97 to 751       655/754
(86 %)
22 diff
(97.1 %id)
CN347168 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 UBE2J2.n 885 to 1462 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
AA808008 germinal center B cell UBE2J2.n 887 to 1399 534 to 27   AAA   508/508
(100 %)
7 diff
(98.7 %id)
CA423988 cell lines, Chondrosarcoma UBE2J2.n 889 to 1399 529 to 19   AAA   511/511
(100 %)
8 diff
(98.5 %id)
CA426485 cell lines, Chondrosarcoma UBE2J2.n 891 to 1399 528 to 19   AAA   510/510
(100 %)
4 diff
(99.3 %id)
AW615212 Kidney UBE2J2.n 897 to 1399 503 to 1       503/503
(100 %)
1 diff
(99.9 %id)
CK431124 eye, lacrimal gland UBE2J2.n 900 to 1399 1 to 500   AAA   500/500
(100 %)
0 diff
(100 %id)
BF310765 brain, neuroblastoma UBE2J2.n 917 to 1663 1 to 732       732/861
(85 %)
25 diff
(97.1 %id)
BQ028877 Bone, Subchondral Bone UBE2J2.n 933 to 1399 485 to 19   AAA   467/467
(100 %)
1 diff
(99.8 %id)
BE298978 muscle, rhabdomyosarcoma UBE2J2.n 937 to 1536 1 to 597       597/598
(99 %)
4 diff
(99.4 %id)
BE297403 muscle, rhabdomyosarcoma UBE2J2.n 938 to 1609 1 to 668       668/721
(92 %)
13 diff
(98.2 %id)
AA928695 adenocarcinoma, colon UBE2J2.n 941 to 1399 458 to 1       458/458
(100 %)
6 diff
(98.7 %id)
AI187207   UBE2J2.n 941 to 1400 463 to 4       460/463
(99 %)
0 diff
(100 %id)
AI620631 Prostate UBE2J2.n 947 to 1400 460 to 5       456/460
(99 %)
0 diff
(100 %id)
AA938128 carcinoid, lung UBE2J2.n 951 to 1400 457 to 9       449/457
(98 %)
0 diff
(100 %id)
AI346527 adenocarcinoma, colon UBE2J2.n 952 to 1399 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AA808401 germinal center B cell UBE2J2.n 953 to 1399 460 to 15   AAA   446/446
(100 %)
5 diff
(98.9 %id)
AI040261 senescent fibroblast UBE2J2.n 953 to 1400 454 to 7       448/454
(98 %)
0 diff
(100 %id)
AI440313 B-cell, chronic lymphotic leukemia UBE2J2.n 955 to 1399 456 to 12   AAA   445/445
(100 %)
0 diff
(100 %id)
AW130326 poorly differentiated adenocarcinoma withsignet ring cell features, stomach UBE2J2.n 955 to 1400 447 to 1       447/447
(100 %)
3 diff
(99.4 %id)
AA868693   UBE2J2.n 969 to 1400 434 to 3       432/434
(99 %)
0 diff
(100 %id)
AI653329 pooled germ cell tumors UBE2J2.n 978 to 1400 425 to 3       423/425
(99 %)
0 diff
(100 %id)
AI147844 senescent fibroblast UBE2J2.n 979 to 1400 428 to 7       422/428
(98 %)
0 diff
(100 %id)
AI332462 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 979 to 1399 442 to 22   AAA   421/421
(100 %)
4 diff
(99.1 %id)
AA732147 germinal center B cell UBE2J2.n 980 to 1399 434 to 17   AAA   418/418
(100 %)
5 diff
(98.9 %id)
AA782611 parathyroid gland, parathyroid tumor UBE2J2.n 985 to 1400 424 to 9       416/424
(98 %)
0 diff
(100 %id)
AI140982 anaplastic oligodendroglioma, brain UBE2J2.n 985 to 1400 419 to 4       416/419
(99 %)
0 diff
(100 %id)
AI023036 senescent fibroblast UBE2J2.n 991 to 1400 415 to 7       409/415
(98 %)
0 diff
(100 %id)
AW402901 lymph UBE2J2.n 991 to 1292 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
AI457503 carcinoid, lung UBE2J2.n 994 to 1399 421 to 16   AAA   406/406
(100 %)
1 diff
(99.8 %id)
AI391483 B-cell, chronic lymphotic leukemia UBE2J2.n 999 to 1400 403 to 2       402/403
(99 %)
0 diff
(100 %id)
BE328408 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney UBE2J2.n 1005 to 1400 397 to 2       396/402
(98 %)
0 diff
(100 %id)
AA988832 carcinoid, lung UBE2J2.n 1014 to 1399 385 to 1       385/385
(100 %)
7 diff
(98.2 %id)
AI077635 senescent fibroblast UBE2J2.n 1014 to 1398 390 to 8       383/390
(98 %)
0 diff
(100 %id)
AI094177 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1014 to 1400 389 to 4       386/389
(99 %)
0 diff
(100 %id)
AA716049 pineal gland UBE2J2.n 1015 to 1400 389 to 3       387/389
(99 %)
0 diff
(100 %id)
W90622 liver and spleen UBE2J2.n 1015 to 1399 386 to 1       386/386
(100 %)
6 diff
(98.5 %id)
AA236525 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1018 to 1399 392 to 12   AAA   381/381
(100 %)
1 diff
(99.8 %id)
AJ713593 bone marrow UBE2J2.n 1021 to 1376 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
AI283828 adenocarcinoma, colon UBE2J2.n 1021 to 1399 379 to 1       379/379
(100 %)
0 diff
(100 %id)
BG179292 adenocarcinoma, cell line, Prostate UBE2J2.n 1030 to 1399 1 to 371   AAA   371/371
(100 %)
1 diff
(99.8 %id)
AI332478 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1035 to 1399 385 to 22   AAA   364/364
(100 %)
4 diff
(99.0 %id)
BI491466 cochlea, ear UBE2J2.n 1041 to 1403 366 to 5       362/372
(97 %)
0 diff
(100 %id)
TI_149298103   UBE2J2.n 1048 to 1860 850 to 45       806/984
(81 %)
0 diff
(100 %id)
CB854875 lung, Primary Lung Cystic Fibrosis EpithelialCells UBE2J2.n 1048 to 1765 711 to 1       711/722
(98 %)
11 diff
(98.5 %id)
BM728336 eye, fetal eye UBE2J2.n 1061 to 1560 1 to 499       499/499
(100 %)
3 diff
(99.4 %id)
CB048650 Prostate UBE2J2.n 1062 to 1399 9 to 346   AAA   338/346
(97 %)
0 diff
(100 %id)
BM354020 Islets of Langerhans, Pancreas UBE2J2.n 1065 to 1399 1 to 335   AAA   335/335
(100 %)
1 diff
(99.8 %id)
BM142230 Islets of Langerhans, Pancreas UBE2J2.n 1065 to 1399 1 to 335   AAA   335/335
(100 %)
1 diff
(99.8 %id)
AI825236 pooled germ cell tumors UBE2J2.n 1072 to 1400 329 to 1       329/329
(100 %)
0 diff
(100 %id)
CD517305 White Matter UBE2J2.n 1079 to 1399 27 to 347   AAA   321/347
(92 %)
6 diff
(98.3 %id)
R76329 placenta UBE2J2.n 1080 to 1329 1 to 253   fully sequenced,   253/253
(100 %)
4 diff
(98.5 %id)
AI536666 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus UBE2J2.n 1081 to 1399 318 to 1       318/318
(100 %)
1 diff
(99.7 %id)
BG036255 adenocarcinoma, cell line, Prostate UBE2J2.n 1082 to 1755 1 to 671       671/671
(100 %)
6 diff
(99.2 %id)
CR598255 Neuroblastoma Cot 25-normalized UBE2J2.n 1087 to 1400 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BX354240 Neuroblastoma Cot 25-normalized UBE2J2.n 1087 to 1400 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BQ013163 placenta UBE2J2.n 1091 to 1399 327 to 19   AAA   309/313
(98 %)
3 diff
(99.1 %id)
C06192   UBE2J2.n 1103 to 1400 305 to 8       298/529
(56 %)
0 diff
(100 %id)
AA435692.
matches multiple genes
  UBE2J2.n 1103 to 1400 301 to 4     also hits gene gleejaw 298/301
(99 %)
0 diff
(100 %id)
AA292512 ovarian tumor, ovary UBE2J2.n 1104 to 1385 5 to 283   fully sequenced,   279/283
(98 %)
10 diff
(96.5 %id)
AA428346 ovarian tumor, ovary UBE2J2.n 1104 to 1393 5 to 295   fully sequenced,   291/295
(98 %)
9 diff
(97.0 %id)
AA767813 germinal center B cell UBE2J2.n 1109 to 1399 307 to 17   AAA   291/291
(100 %)
3 diff
(99.0 %id)
AA419317 ovarian tumor, ovary UBE2J2.n 1111 to 1434 15 to 345       331/345
(95 %)
6 diff
(98.3 %id)
AA410850 ovarian tumor, ovary UBE2J2.n 1114 to 1520 1 to 404       404/404
(100 %)
4 diff
(99.1 %id)
BM740566 Ascites, stomach UBE2J2.n 1118 to 1358 1 to 243       243/243
(100 %)
3 diff
(98.8 %id)
BI116136 lung, small cell carcinoma UBE2J2.n 1120 to 1918 1 to 813   available from MGC,   813/824
(98 %)
30 diff
(96.4 %id)
BC052579 Lung, small cell carcinoma UBE2J2.n 1121 to 2380 1 to 1260   available from MGC, AAA   1260/1260
(100 %)
0 diff
(100 %id)
AA478896 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1123 to 1489 1 to 366   fully sequenced,   366/366
(100 %)
1 diff
(99.8 %id)
BE392860 endometrium, adenocarcinoma cell line, uterus UBE2J2.n 1125 to 1398 12 to 282       271/282
(96 %)
6 diff
(97.9 %id)
AA434151 ovarian tumor, ovary UBE2J2.n 1128 to 1568 1 to 440     Submitted on the opposite strand 440/440
(100 %)
2 diff
(99.6 %id)
BX497098 Liver UBE2J2.n 1138 to 1399 1 to 262   AAA   262/262
(100 %)
4 diff
(98.5 %id)
BI438797 Pancreas, Purified pancreatic islet UBE2J2.n 1150 to 1765 617 to 2       616/617
(99 %)
0 diff
(100 %id)
AW079350 colon, moderately differentiated adenocarcinoma UBE2J2.n 1150 to 1394 284 to 40   AAA   245/250
(98 %)
0 diff
(100 %id)
AI363037 anaplastic oligodendroglioma, brain UBE2J2.n 1152 to 1402 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AA257966 germinal center B cell UBE2J2.n 1167 to 1399 261 to 29   AAA   233/233
(100 %)
2 diff
(99.2 %id)
BG472357 eye, retinoblastoma UBE2J2.n 1170 to 2019 1 to 850   available from MGC,   850/850
(100 %)
10 diff
(98.9 %id)
BC027728 Eye, retinoblastoma UBE2J2.n 1171 to 2380 1 to 1210   available from MGC, AAA   1210/1210
(100 %)
0 diff
(100 %id)
BM925084 pooled lung and spleen UBE2J2.n 1174 to 1755 8 to 589       582/589
(98 %)
8 diff
(98.7 %id)
BM997346 lung, Metastatic Chondrosarcoma UBE2J2.n 1175 to 1394 244 to 24   AAA   221/226
(97 %)
0 diff
(100 %id)
AW612258 carcinoid, lung UBE2J2.n 1176 to 1398 224 to 1       224/224
(100 %)
1 diff
(99.6 %id)
BE257453 eye, retinoblastoma UBE2J2.n 1190 to 1611 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
AI363903 anaplastic oligodendroglioma, brain UBE2J2.n 1204 to 1399 197 to 1       197/197
(100 %)
1 diff
(99.5 %id)
BF590761 colon, colon tumor, RER+ UBE2J2.n 1204 to 1399 207 to 11   AAA   197/197
(100 %)
1 diff
(99.5 %id)
BM151680 leukopheresis UBE2J2.n 1208 to 1483 1 to 276       276/317
(87 %)
12 diff
(96.3 %id)
BI752703 brain UBE2J2.n 1225 to 1757 1 to 532       532/532
(100 %)
1 diff
(99.9 %id)
TI_57219539   UBE2J2.n 1225 to 1765 30 to 569       540/888
(60 %)
2 diff
(99.8 %id)
T25864   UBE2J2.n 1227 to 1399 171 to 1       171/172
(99 %)
4 diff
(97.7 %id)
AA482488 ovarian tumor, ovary UBE2J2.n 1236 to 1765 534 to 1       534/534
(100 %)
10 diff
(98.2 %id)
BF056646 fibrotheoma, ovary UBE2J2.n 1243 to 1765 523 to 1       523/523
(100 %)
1 diff
(99.9 %id)
AI347999 adenocarcinoma, colon UBE2J2.n 1247 to 1765 519 to 1       519/519
(100 %)
4 diff
(99.3 %id)
AI784467 anaplastic oligodendroglioma, brain UBE2J2.n 1250 to 1402 153 to 1       153/153
(100 %)
0 diff
(100 %id)
AA741123 germinal center B cell UBE2J2.n 1260 to 1695 433 to 1       433/434
(99 %)
6 diff
(98.7 %id)
AA854955 parathyroid gland, parathyroid tumor UBE2J2.n 1266 to 1753 487 to 1       487/487
(100 %)
4 diff
(99.2 %id)
AI659942 colon, colonic mucosa from 3 patients with Crohn'sdisease UBE2J2.n 1269 to 1765 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AI741649 pooled UBE2J2.n 1269 to 1747 480 to 1       480/480
(100 %)
1 diff
(99.8 %id)
AW517321 cervix UBE2J2.n 1280 to 1765 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
BF514760   UBE2J2.n 1296 to 1764 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
R76659 placenta UBE2J2.n 1299 to 1679 385 to 1   fully sequenced,   385/385
(100 %)
6 diff
(98.5 %id)
AI184871 pooled UBE2J2.n 1304 to 1747 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AW173162 pooled UBE2J2.n 1307 to 1765 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AA845898 Spleen UBE2J2.n 1308 to 1679 372 to 1       372/372
(100 %)
0 diff
(100 %id)
EC442576 Prostate UBE2J2.n 1310 to 1400 12 to 103       92/103
(89 %)
6 diff
(94.2 %id)
EC558733 Prostate UBE2J2.n 1310 to 1399 13 to 102       90/105
(85 %)
3 diff
(97.2 %id)
AI186896 lung UBE2J2.n 1312 to 1747 436 to 1       436/436
(100 %)
11 diff
(97.5 %id)
AA425161 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1327 to 1765 441 to 2       440/441
(99 %)
0 diff
(100 %id)
AI003848   UBE2J2.n 1327 to 1679 353 to 1       353/353
(100 %)
4 diff
(98.9 %id)
AI673262 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus UBE2J2.n 1327 to 1733 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
AI240625 pooled UBE2J2.n 1329 to 1765 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
AI250944 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1339 to 1679 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AW473695 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE2J2.n 1343 to 1765 424 to 2       423/424
(99 %)
0 diff
(100 %id)
H72037 breast UBE2J2.n 1347 to 1679 348 to 1       348/356
(97 %)
16 diff
(95.6 %id)
AI140287 lung UBE2J2.n 1351 to 1765 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AA235470 ovarian tumor, ovary UBE2J2.n 1355 to 1765 410 to 1   fully sequenced,   410/410
(100 %)
8 diff
(98.1 %id)
AW664982 pooled UBE2J2.n 1356 to 1765 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AW300690 colon, moderately differentiated adenocarcinoma UBE2J2.n 1357 to 1744 388 to 1       388/388
(100 %)
4 diff
(99.0 %id)
AA425830 ovarian tumor, ovary UBE2J2.n 1363 to 1679 317 to 1   fully sequenced,   317/317
(100 %)
0 diff
(100 %id)
AW149575 brain, medulloblastoma UBE2J2.n 1373 to 1765 398 to 1       398/398
(100 %)
11 diff
(97.3 %id)
BM931427 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE2J2.n 1379 to 1757 1 to 379       379/379
(100 %)
0 diff
(100 %id)
TI_151763571   UBE2J2.n 1379 to 1769 433 to 43       391/981
(39 %)
0 diff
(100 %id)
AA813090   UBE2J2.n 1399 to 1765 368 to 2       367/368
(99 %)
0 diff
(100 %id)
AI198250 anaplastic oligodendroglioma, brain UBE2J2.n 1405 to 1747 342 to 1       342/342
(100 %)
1 diff
(99.8 %id)
AW051140 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE2J2.n 1455 to 1733 281 to 1       281/281
(100 %)
2 diff
(99.3 %id)
AA478777 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1459 to 1765 307 to 1   fully sequenced,   307/307
(100 %)
1 diff
(99.7 %id)
AW573007 pooled UBE2J2.n 1482 to 1765 284 to 1       284/290
(97 %)
0 diff
(100 %id)
AI559362 anaplastic oligodendroglioma, brain UBE2J2.n 1489 to 1765 277 to 1       277/279
(99 %)
1 diff
(99.7 %id)
AA447706 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE2J2.n 1497 to 1763 268 to 2       267/268
(99 %)
0 diff
(100 %id)
BM719122 eye, fetal eye UBE2J2.n 1537 to 2002 1 to 466   fully sequenced,   466/466
(100 %)
2 diff
(99.6 %id)
BF941524 brain, glioblastoma (pooled) UBE2J2.n 1542 to 1679 138 to 1       138/138
(100 %)
4 diff
(97.2 %id)
AA235624 ovarian tumor, ovary UBE2J2.n 1563 to 1765 203 to 1       203/203
(100 %)
4 diff
(98.1 %id)
AI302942 2 pooled tumors (clear cell type), Kidney UBE2J2.n 1564 to 1765 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AA627460 colon, colon tumor RER+ UBE2J2.n 1590 to 1763 178 to 2       177/178
(99 %)
0 diff
(100 %id)
AA419266 ovarian tumor, ovary UBE2J2.n 1592 to 1765 174 to 1       174/174
(100 %)
1 diff
(99.5 %id)
AI361168 brain, glioblastoma (pooled) UBE2J2.n 1592 to 1765 171 to 1       283/312
(90 %)
14 diff
(95.6 %id)
AI566228 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) UBE2J2.n 1758 to 2232 1 to 475     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
AW167553 cervix UBE2J2.n 1758 to 2284 1 to 527     Submitted on the opposite strand 527/527
(100 %)
0 diff
(100 %id)
AW628793 pooled UBE2J2.n 1758 to 2148 1 to 394     Submitted on the opposite strand 394/407
(96 %)
4 diff
(99.1 %id)
BE041625 pooled UBE2J2.n 1758 to 2099 1 to 342     Submitted on the opposite strand 342/342
(100 %)
0 diff
(100 %id)
BF513990   UBE2J2.n 1759 to 2250 1 to 492     Submitted on the opposite strand 492/494
(99 %)
1 diff
(99.8 %id)
BF516313   UBE2J2.n 1759 to 2176 1 to 418     Submitted on the opposite strand 418/418
(100 %)
3 diff
(99.3 %id)
AI796182 Kidney UBE2J2.n 1763 to 2284 1 to 522     Submitted on the opposite strand 522/522
(100 %)
5 diff
(99.1 %id)
AF116687 Liver UBE2J2.n 1766 to 2375 626 to 17     Submitted on the opposite strand 610/626
(97 %)
0 diff
(100 %id)
AI133509 Liver UBE2J2.n 1766 to 2374 627 to 18   AAA   610/610
(100 %)
1 diff
(99.9 %id)
AI369885 anaplastic oligodendroglioma, brain UBE2J2.n 1776 to 2236 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
BF476166 Kidney UBE2J2.n 1793 to 2159 1 to 367     Submitted on the opposite strand 367/367
(100 %)
0 diff
(100 %id)
EC566378 Prostate UBE2J2.n 1842 to 1950 1 to 106       106/106
(100 %)
5 diff
(95.3 %id)
BM852078 stomach UBE2J2.n 1877 to 2318 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
DB329536 Prostate UBE2J2.n 1898 to 2379 495 to 13       483/495
(97 %)
0 diff
(100 %id)
DB526784 testis UBE2J2.n 1924 to 2387 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
DB525332 testis UBE2J2.n 1947 to 2385 1 to 439     Submitted on the opposite strand 439/441
(99 %)
2 diff
(99.6 %id)
DB519382 testis UBE2J2.n 1953 to 2387 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AW590517 pooled germ cell tumors UBE2J2.n 1965 to 2388 423 to 1       423/456
(92 %)
5 diff
(99.0 %id)
AI369622 anaplastic oligodendroglioma, brain UBE2J2.n 1969 to 2387 419 to 1       419/419
(100 %)
0 diff
(100 %id)
BM683083 eye, fetal eye UBE2J2.n 1972 to 2387 434 to 19   fully sequenced, AAA   416/416
(100 %)
1 diff
(99.8 %id)
D61132   UBE2J2.n 1982 to 2338 1 to 354       354/354
(100 %)
7 diff
(98.1 %id)
BX096192 anaplastic oligodendroglioma, brain UBE2J2.n 2219 to 2392 188 to 15   tiling clone, AAA   174/174
(100 %)
1 diff
(99.5 %id)
BQ377693 uterus UBE2J2.n 2225 to 2354 149 to 21       129/156
(82 %)
0 diff
(100 %id)
BG721041 testis UBE2J2.o 1 to 643 1 to 644   tiling clone,   644/669
(96 %)
7 diff
(99.0 %id)
DA732950   UBE2J2.o 30 to 590 2 to 561   tiling clone, capped   560/562
(99 %)
4 diff
(99.3 %id)
BI907391 leukocyte UBE2J2.o 43 to 643 1 to 601       601/636
(94 %)
5 diff
(99.3 %id)
TI_57232591   UBE2J2.o 43 to 643 33 to 633       601/668
(89 %)
10 diff
(98.6 %id)
BG110522 Bone, osteosarcoma, cell line UBE2J2.o 607 to 823 1 to 217   tiling clone, AAA   217/217
(100 %)
0 diff
(100 %id)
DB364654   UBE2J2.o 1336 to 1817 481 to 1   tiling clone,   481/481
(100 %)
16 diff
(96.7 %id)
BM543509 brain, hippocampus UBE2J2.p 1 to 848 20 to 882 F163V F166L V170G K171Q L174A ... tiling clone,   866/1048
(82 %)
41 diff
(96.1 %id)
BX343049   UBE2J2.q 1 to 886 1 to 883   tiling clone,   883/883
(100 %)
6 diff
(99.4 %id)
BG766070 melanotic melanoma, high MDR (cell line), skin UBE2J2.r 1 to 639 5 to 642   tiling clone,   642/642
(100 %)
1 diff
(99.9 %id)
BM693649 eye, fetal eyes UBE2J2.r 628 to 1080 1 to 452   tiling clone, fully sequenced,   452/452
(100 %)
1 diff
(99.8 %id)
BM669232 eye, fetal eyes UBE2J2.r 1050 to 1459 427 to 19   tiling clone, fully sequenced, AAA   409/409
(100 %)
3 diff
(99.3 %id)
BG548442 lung UBE2J2.s 1 to 833 6 to 853 W149G tiling clone,   853/853
(100 %)
35 diff
(95.9 %id)
CD672671 eye, Iris UBE2J2.t 1 to 656 1 to 656 exact tiling clone,   656/656
(100 %)
0 diff
(100 %id)
DA147284 amygdala UBE2J2.u 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
AW612697 carcinoid, lung UBE2J2.va 1 to 515 1 to 515 exact tiling clone, Submitted on the opposite strand 515/515
(100 %)
0 diff
(100 %id)
BI439116 Pancreas, Purified pancreatic islet UBE2J2.vb 1 to 615 1 to 615 exact tiling clone,   615/616
(99 %)
5 diff
(99.2 %id)
BM920925 pooled brain, lung, testis UBE2J2.vc 1 to 472 8 to 479   tiling clone,   472/487
(96 %)
8 diff
(98.4 %id)
BM919982 pooled pancreas and spleen UBE2J2.vc 5 to 545 1 to 545   tiling clone,   545/1194
(45 %)
8 diff
(99.4 %id)
BI913221 brain UBE2J2.vc 341 to 1120 1 to 779   tiling clone,   779/779
(100 %)
3 diff
(99.7 %id)
TI_57240408   UBE2J2.vc 341 to 1120 36 to 814       779/814
(95 %)
8 diff
(99.1 %id)
BM044633 carcinoma, cell line, Prostate UBE2J2.vc 399 to 1191 1 to 804 T11N T12H A13G T14N Q15P ... tiling clone,   802/805
(99 %)
22 diff
(97.3 %id)
BQ937191 carcinoma, cell line, Prostate UBE2J2.vc 402 to 1044 1 to 647       647/1034
(62 %)
16 diff
(98.5 %id)
BE612630 adenocarcinoma, ovary UBE2J2.vd-u 1 to 612 1 to 610 exact tiling clone,   610/1049
(58 %)
4 diff
(99.7 %id)
DB044521 testis UBE2J2.ve 1 to 547 2 to 548 exact tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
DA297955 hippocampus UBE2J2.vf -9 to 519 2 to 531 exact tiling clone, capped   530/530
(100 %)
2 diff
(99.7 %id)
BM794599 stomach UBE2J2.vg 1 to 472 1 to 472 exact tiling clone,   472/472
(100 %)
0 diff
(100 %id)
BI002559 head_normal UBE2J2.vh 1 to 334 10 to 344 exact tiling clone,   335/346
(96 %)
11 diff
(96.9 %id)
BI030620 marrow UBE2J2.vi-u 1 to 286 287 to 3 G14V G21R S22L Q23T R24E ... tiling clone,   285/289
(98 %)
0 diff
(100 %id)
AK094155.
matches multiple genes
  Gene sonura, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored, also hits gene sonura    
AK094155.
matches multiple genes
  Gene UBE2J2, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored, also hits gene sonura    
AA425266   Gene UBE2J2, variant not shown         This clone was ignored    
AA425875   Gene UBE2J2, variant not shown         This clone was ignored    
AI338295 lung Gene UBE2J2, variant not shown         Suspected internal deletion, this clone was ignored    
AW411508 muscle, rhabdomyosarcoma Gene UBE2J2, variant not shown         This clone was ignored    
AW411509 muscle, rhabdomyosarcoma Gene UBE2J2, variant not shown         This clone was ignored    
BE515187 endometrium, adenocarcinoma cell line, uterus Gene UBE2J2, variant not shown         Suspected internal deletion, this clone was ignored    
BG717336 testis Gene UBE2J2, variant not shown         This clone was ignored    
DA784015 brain Gene UBE2J2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB151116 thymus Gene UBE2J2, variant not shown       capped This clone was ignored    
DB346138 thymus Gene UBE2J2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd-u, .ve, .vf, .vg, .vh, .vi-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI